Peptide‐Based Hydrogel for Nanosystems Encapsulation: the Next Generation of Localized Delivery Systems for the Treatment of Intestinal Inflammations

Conventional therapies for inflammatory bowel diseases are mainly based on systemic treatments which cause side effects and toxicity over long‐term administration. Nanoparticles appear as a valid alternative to allow a preferential accumulation in inflamed tissues following oral administration while...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Advanced healthcare materials 2024-06, Vol.13 (16), p.e2303280-n/a
Hauptverfasser: Andretto, Valentina, Rosso, Annalisa, Zilio, Serena, Sidi‐Boumedine, Jacqueline, Boschetti, Gilles, Sankar, Sharanya, Buffier, Marie, Miele, Adriana Erica, Denis, Morgane, Choffour, Pierre‐Antoine, Briançon, Stéphanie, Nancey, Stéphane, Kryza, David, Lollo, Giovanna
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 16
container_start_page e2303280
container_title Advanced healthcare materials
container_volume 13
creator Andretto, Valentina
Rosso, Annalisa
Zilio, Serena
Sidi‐Boumedine, Jacqueline
Boschetti, Gilles
Sankar, Sharanya
Buffier, Marie
Miele, Adriana Erica
Denis, Morgane
Choffour, Pierre‐Antoine
Briançon, Stéphanie
Nancey, Stéphane
Kryza, David
Lollo, Giovanna
description Conventional therapies for inflammatory bowel diseases are mainly based on systemic treatments which cause side effects and toxicity over long‐term administration. Nanoparticles appear as a valid alternative to allow a preferential accumulation in inflamed tissues following oral administration while reducing systemic drug exposure. To increase their residence time in the inflamed intestine, the nanoparticles are here associated with a hydrogel matrix. A bioadhesive peptide‐based hydrogel is mixed with nanoemulsions, creating a hybrid lipid‐polymer nanocomposite. Mucopenetrating nanoemulsions of 100 nm are embedded in a scaffold constituted of the self‐assembling peptide hydrogel product PuraStat. The nanocomposite is fully characterized to study the impact of lipid particles in the hydrogel structure. Rheological measurements and circular dichroism analyses are performed to investigate the system's microstructure and physical properties. Biodistribution studies demonstrate that the nanocomposite acts as a depot in the stomach and facilitates the slow release of the nanoemulsions in the intestine. Efficacy studies upon oral administration of the drug‐loaded system show the improvement of the disease score in a mouse model of intestinal inflammation. Local manipulation of immunological pathways causing intestinal inflammation represents a promising strategy for inflammatory bowel diseases treatment. Here, oral hybrid lipid‐polymer nanocomposite made of bioadhesive peptide‐based hydrogel mixed with tofacitinib‐loaded nanoemulsions for local intestinal immunomodulation is designed. The feasibility of the nanocomposite platform and the efficacy upon oral administration in a mouse model of intestinal inflammation are demonstrated.
doi_str_mv 10.1002/adhm.202303280
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_04526888v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3071691073</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4070-d8e4b156460dbb8cb98381dad24b42c0ddf6b2d6711f99baf6fdc8d0d70762103</originalsourceid><addsrcrecordid>eNqFkc9u1DAQhyMEolXplSOyxAUOu4wdx3G4Lf23lZaCRDlbTjxhUznx1k4K6YlH4Mb78SQ43WWRuOCLR6NvPs3olyTPKcwpAHujzbqdM2AppEzCo-SQ0YLNmMiKx_uaw0FyHMINxCcyKiR9mhykkvNMUnaY_PyIm74x-Ov7j3c6oCHL0Xj3BS2pnSdXunNhDD22gZx1ld6Eweq-cd1b0q-RXOG3nlxgh_6hSVxNVq7StrmPolO0zR36kXzaCSbhNHXtUfctdv3EX3Y9hr7ptI1lbXXbPqjCs-RJrW3A491_lHw-P7s-Wc5WHy4uTxarWcUhh5mRyEuaCS7AlKWsykKmkhptGC85q8CYWpTMiJzSuihKXYvaVNKAySEXjEJ6lLzeetfaqo1vWu1H5XSjlouVmnrAMyaklHc0sq-27Ma72yGurdomVGit7tANQbEilUwWjGcRffkPeuMGH68MKoWcioJCnkZqvqUq70LwWO83oKCmhNWUsNonHAde7LRD2aLZ43_yjECxBb42Fsf_6NTidPn-r_w3kcu0jw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3071691073</pqid></control><display><type>article</type><title>Peptide‐Based Hydrogel for Nanosystems Encapsulation: the Next Generation of Localized Delivery Systems for the Treatment of Intestinal Inflammations</title><source>Wiley Online Library - AutoHoldings Journals</source><creator>Andretto, Valentina ; Rosso, Annalisa ; Zilio, Serena ; Sidi‐Boumedine, Jacqueline ; Boschetti, Gilles ; Sankar, Sharanya ; Buffier, Marie ; Miele, Adriana Erica ; Denis, Morgane ; Choffour, Pierre‐Antoine ; Briançon, Stéphanie ; Nancey, Stéphane ; Kryza, David ; Lollo, Giovanna</creator><creatorcontrib>Andretto, Valentina ; Rosso, Annalisa ; Zilio, Serena ; Sidi‐Boumedine, Jacqueline ; Boschetti, Gilles ; Sankar, Sharanya ; Buffier, Marie ; Miele, Adriana Erica ; Denis, Morgane ; Choffour, Pierre‐Antoine ; Briançon, Stéphanie ; Nancey, Stéphane ; Kryza, David ; Lollo, Giovanna</creatorcontrib><description>Conventional therapies for inflammatory bowel diseases are mainly based on systemic treatments which cause side effects and toxicity over long‐term administration. Nanoparticles appear as a valid alternative to allow a preferential accumulation in inflamed tissues following oral administration while reducing systemic drug exposure. To increase their residence time in the inflamed intestine, the nanoparticles are here associated with a hydrogel matrix. A bioadhesive peptide‐based hydrogel is mixed with nanoemulsions, creating a hybrid lipid‐polymer nanocomposite. Mucopenetrating nanoemulsions of 100 nm are embedded in a scaffold constituted of the self‐assembling peptide hydrogel product PuraStat. The nanocomposite is fully characterized to study the impact of lipid particles in the hydrogel structure. Rheological measurements and circular dichroism analyses are performed to investigate the system's microstructure and physical properties. Biodistribution studies demonstrate that the nanocomposite acts as a depot in the stomach and facilitates the slow release of the nanoemulsions in the intestine. Efficacy studies upon oral administration of the drug‐loaded system show the improvement of the disease score in a mouse model of intestinal inflammation. Local manipulation of immunological pathways causing intestinal inflammation represents a promising strategy for inflammatory bowel diseases treatment. Here, oral hybrid lipid‐polymer nanocomposite made of bioadhesive peptide‐based hydrogel mixed with tofacitinib‐loaded nanoemulsions for local intestinal immunomodulation is designed. The feasibility of the nanocomposite platform and the efficacy upon oral administration in a mouse model of intestinal inflammation are demonstrated.</description><identifier>ISSN: 2192-2640</identifier><identifier>ISSN: 2192-2659</identifier><identifier>EISSN: 2192-2659</identifier><identifier>DOI: 10.1002/adhm.202303280</identifier><identifier>PMID: 38445812</identifier><language>eng</language><publisher>Germany: Wiley Subscription Services, Inc</publisher><subject>Bioaccumulation ; Circular dichroism ; Dichroism ; Galenic pharmacology ; hybrid systems ; Hydrogels ; Inflammatory bowel diseases ; inflammatory bowel diseases (IBDs) ; Intestine ; Life Sciences ; Lipids ; Nanocomposites ; Nanoemulsions ; Nanoparticles ; Oral administration ; oral delivery ; Peptides ; Pharmaceutical sciences ; Pharmacology ; Physical properties ; Rheological properties ; Self-assembly ; Side effects ; Toxicity</subject><ispartof>Advanced healthcare materials, 2024-06, Vol.13 (16), p.e2303280-n/a</ispartof><rights>2024 Wiley‐VCH GmbH</rights><rights>This article is protected by copyright. All rights reserved.</rights><rights>2024 Wiley‐VCH GmbH.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4070-d8e4b156460dbb8cb98381dad24b42c0ddf6b2d6711f99baf6fdc8d0d70762103</citedby><cites>FETCH-LOGICAL-c4070-d8e4b156460dbb8cb98381dad24b42c0ddf6b2d6711f99baf6fdc8d0d70762103</cites><orcidid>0000-0001-7030-3056 ; 0000-0003-2088-1442</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fadhm.202303280$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fadhm.202303280$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,777,781,882,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38445812$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-04526888$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Andretto, Valentina</creatorcontrib><creatorcontrib>Rosso, Annalisa</creatorcontrib><creatorcontrib>Zilio, Serena</creatorcontrib><creatorcontrib>Sidi‐Boumedine, Jacqueline</creatorcontrib><creatorcontrib>Boschetti, Gilles</creatorcontrib><creatorcontrib>Sankar, Sharanya</creatorcontrib><creatorcontrib>Buffier, Marie</creatorcontrib><creatorcontrib>Miele, Adriana Erica</creatorcontrib><creatorcontrib>Denis, Morgane</creatorcontrib><creatorcontrib>Choffour, Pierre‐Antoine</creatorcontrib><creatorcontrib>Briançon, Stéphanie</creatorcontrib><creatorcontrib>Nancey, Stéphane</creatorcontrib><creatorcontrib>Kryza, David</creatorcontrib><creatorcontrib>Lollo, Giovanna</creatorcontrib><title>Peptide‐Based Hydrogel for Nanosystems Encapsulation: the Next Generation of Localized Delivery Systems for the Treatment of Intestinal Inflammations</title><title>Advanced healthcare materials</title><addtitle>Adv Healthc Mater</addtitle><description>Conventional therapies for inflammatory bowel diseases are mainly based on systemic treatments which cause side effects and toxicity over long‐term administration. Nanoparticles appear as a valid alternative to allow a preferential accumulation in inflamed tissues following oral administration while reducing systemic drug exposure. To increase their residence time in the inflamed intestine, the nanoparticles are here associated with a hydrogel matrix. A bioadhesive peptide‐based hydrogel is mixed with nanoemulsions, creating a hybrid lipid‐polymer nanocomposite. Mucopenetrating nanoemulsions of 100 nm are embedded in a scaffold constituted of the self‐assembling peptide hydrogel product PuraStat. The nanocomposite is fully characterized to study the impact of lipid particles in the hydrogel structure. Rheological measurements and circular dichroism analyses are performed to investigate the system's microstructure and physical properties. Biodistribution studies demonstrate that the nanocomposite acts as a depot in the stomach and facilitates the slow release of the nanoemulsions in the intestine. Efficacy studies upon oral administration of the drug‐loaded system show the improvement of the disease score in a mouse model of intestinal inflammation. Local manipulation of immunological pathways causing intestinal inflammation represents a promising strategy for inflammatory bowel diseases treatment. Here, oral hybrid lipid‐polymer nanocomposite made of bioadhesive peptide‐based hydrogel mixed with tofacitinib‐loaded nanoemulsions for local intestinal immunomodulation is designed. The feasibility of the nanocomposite platform and the efficacy upon oral administration in a mouse model of intestinal inflammation are demonstrated.</description><subject>Bioaccumulation</subject><subject>Circular dichroism</subject><subject>Dichroism</subject><subject>Galenic pharmacology</subject><subject>hybrid systems</subject><subject>Hydrogels</subject><subject>Inflammatory bowel diseases</subject><subject>inflammatory bowel diseases (IBDs)</subject><subject>Intestine</subject><subject>Life Sciences</subject><subject>Lipids</subject><subject>Nanocomposites</subject><subject>Nanoemulsions</subject><subject>Nanoparticles</subject><subject>Oral administration</subject><subject>oral delivery</subject><subject>Peptides</subject><subject>Pharmaceutical sciences</subject><subject>Pharmacology</subject><subject>Physical properties</subject><subject>Rheological properties</subject><subject>Self-assembly</subject><subject>Side effects</subject><subject>Toxicity</subject><issn>2192-2640</issn><issn>2192-2659</issn><issn>2192-2659</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqFkc9u1DAQhyMEolXplSOyxAUOu4wdx3G4Lf23lZaCRDlbTjxhUznx1k4K6YlH4Mb78SQ43WWRuOCLR6NvPs3olyTPKcwpAHujzbqdM2AppEzCo-SQ0YLNmMiKx_uaw0FyHMINxCcyKiR9mhykkvNMUnaY_PyIm74x-Ov7j3c6oCHL0Xj3BS2pnSdXunNhDD22gZx1ld6Eweq-cd1b0q-RXOG3nlxgh_6hSVxNVq7StrmPolO0zR36kXzaCSbhNHXtUfctdv3EX3Y9hr7ptI1lbXXbPqjCs-RJrW3A491_lHw-P7s-Wc5WHy4uTxarWcUhh5mRyEuaCS7AlKWsykKmkhptGC85q8CYWpTMiJzSuihKXYvaVNKAySEXjEJ6lLzeetfaqo1vWu1H5XSjlouVmnrAMyaklHc0sq-27Ma72yGurdomVGit7tANQbEilUwWjGcRffkPeuMGH68MKoWcioJCnkZqvqUq70LwWO83oKCmhNWUsNonHAde7LRD2aLZ43_yjECxBb42Fsf_6NTidPn-r_w3kcu0jw</recordid><startdate>20240601</startdate><enddate>20240601</enddate><creator>Andretto, Valentina</creator><creator>Rosso, Annalisa</creator><creator>Zilio, Serena</creator><creator>Sidi‐Boumedine, Jacqueline</creator><creator>Boschetti, Gilles</creator><creator>Sankar, Sharanya</creator><creator>Buffier, Marie</creator><creator>Miele, Adriana Erica</creator><creator>Denis, Morgane</creator><creator>Choffour, Pierre‐Antoine</creator><creator>Briançon, Stéphanie</creator><creator>Nancey, Stéphane</creator><creator>Kryza, David</creator><creator>Lollo, Giovanna</creator><general>Wiley Subscription Services, Inc</general><general>Wiley</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QF</scope><scope>7QP</scope><scope>7QQ</scope><scope>7SC</scope><scope>7SE</scope><scope>7SP</scope><scope>7SR</scope><scope>7T5</scope><scope>7TA</scope><scope>7TB</scope><scope>7TM</scope><scope>7TO</scope><scope>7U5</scope><scope>8BQ</scope><scope>8FD</scope><scope>F28</scope><scope>FR3</scope><scope>H8D</scope><scope>H8G</scope><scope>H94</scope><scope>JG9</scope><scope>JQ2</scope><scope>K9.</scope><scope>KR7</scope><scope>L7M</scope><scope>L~C</scope><scope>L~D</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0001-7030-3056</orcidid><orcidid>https://orcid.org/0000-0003-2088-1442</orcidid></search><sort><creationdate>20240601</creationdate><title>Peptide‐Based Hydrogel for Nanosystems Encapsulation: the Next Generation of Localized Delivery Systems for the Treatment of Intestinal Inflammations</title><author>Andretto, Valentina ; Rosso, Annalisa ; Zilio, Serena ; Sidi‐Boumedine, Jacqueline ; Boschetti, Gilles ; Sankar, Sharanya ; Buffier, Marie ; Miele, Adriana Erica ; Denis, Morgane ; Choffour, Pierre‐Antoine ; Briançon, Stéphanie ; Nancey, Stéphane ; Kryza, David ; Lollo, Giovanna</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4070-d8e4b156460dbb8cb98381dad24b42c0ddf6b2d6711f99baf6fdc8d0d70762103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Bioaccumulation</topic><topic>Circular dichroism</topic><topic>Dichroism</topic><topic>Galenic pharmacology</topic><topic>hybrid systems</topic><topic>Hydrogels</topic><topic>Inflammatory bowel diseases</topic><topic>inflammatory bowel diseases (IBDs)</topic><topic>Intestine</topic><topic>Life Sciences</topic><topic>Lipids</topic><topic>Nanocomposites</topic><topic>Nanoemulsions</topic><topic>Nanoparticles</topic><topic>Oral administration</topic><topic>oral delivery</topic><topic>Peptides</topic><topic>Pharmaceutical sciences</topic><topic>Pharmacology</topic><topic>Physical properties</topic><topic>Rheological properties</topic><topic>Self-assembly</topic><topic>Side effects</topic><topic>Toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Andretto, Valentina</creatorcontrib><creatorcontrib>Rosso, Annalisa</creatorcontrib><creatorcontrib>Zilio, Serena</creatorcontrib><creatorcontrib>Sidi‐Boumedine, Jacqueline</creatorcontrib><creatorcontrib>Boschetti, Gilles</creatorcontrib><creatorcontrib>Sankar, Sharanya</creatorcontrib><creatorcontrib>Buffier, Marie</creatorcontrib><creatorcontrib>Miele, Adriana Erica</creatorcontrib><creatorcontrib>Denis, Morgane</creatorcontrib><creatorcontrib>Choffour, Pierre‐Antoine</creatorcontrib><creatorcontrib>Briançon, Stéphanie</creatorcontrib><creatorcontrib>Nancey, Stéphane</creatorcontrib><creatorcontrib>Kryza, David</creatorcontrib><creatorcontrib>Lollo, Giovanna</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Aluminium Industry Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Ceramic Abstracts</collection><collection>Computer and Information Systems Abstracts</collection><collection>Corrosion Abstracts</collection><collection>Electronics &amp; Communications Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>Immunology Abstracts</collection><collection>Materials Business File</collection><collection>Mechanical &amp; Transportation Engineering Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>ANTE: Abstracts in New Technology &amp; Engineering</collection><collection>Engineering Research Database</collection><collection>Aerospace Database</collection><collection>Copper Technical Reference Library</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Materials Research Database</collection><collection>ProQuest Computer Science Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Civil Engineering Abstracts</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Computer and Information Systems Abstracts – Academic</collection><collection>Computer and Information Systems Abstracts Professional</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Advanced healthcare materials</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Andretto, Valentina</au><au>Rosso, Annalisa</au><au>Zilio, Serena</au><au>Sidi‐Boumedine, Jacqueline</au><au>Boschetti, Gilles</au><au>Sankar, Sharanya</au><au>Buffier, Marie</au><au>Miele, Adriana Erica</au><au>Denis, Morgane</au><au>Choffour, Pierre‐Antoine</au><au>Briançon, Stéphanie</au><au>Nancey, Stéphane</au><au>Kryza, David</au><au>Lollo, Giovanna</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Peptide‐Based Hydrogel for Nanosystems Encapsulation: the Next Generation of Localized Delivery Systems for the Treatment of Intestinal Inflammations</atitle><jtitle>Advanced healthcare materials</jtitle><addtitle>Adv Healthc Mater</addtitle><date>2024-06-01</date><risdate>2024</risdate><volume>13</volume><issue>16</issue><spage>e2303280</spage><epage>n/a</epage><pages>e2303280-n/a</pages><issn>2192-2640</issn><issn>2192-2659</issn><eissn>2192-2659</eissn><abstract>Conventional therapies for inflammatory bowel diseases are mainly based on systemic treatments which cause side effects and toxicity over long‐term administration. Nanoparticles appear as a valid alternative to allow a preferential accumulation in inflamed tissues following oral administration while reducing systemic drug exposure. To increase their residence time in the inflamed intestine, the nanoparticles are here associated with a hydrogel matrix. A bioadhesive peptide‐based hydrogel is mixed with nanoemulsions, creating a hybrid lipid‐polymer nanocomposite. Mucopenetrating nanoemulsions of 100 nm are embedded in a scaffold constituted of the self‐assembling peptide hydrogel product PuraStat. The nanocomposite is fully characterized to study the impact of lipid particles in the hydrogel structure. Rheological measurements and circular dichroism analyses are performed to investigate the system's microstructure and physical properties. Biodistribution studies demonstrate that the nanocomposite acts as a depot in the stomach and facilitates the slow release of the nanoemulsions in the intestine. Efficacy studies upon oral administration of the drug‐loaded system show the improvement of the disease score in a mouse model of intestinal inflammation. Local manipulation of immunological pathways causing intestinal inflammation represents a promising strategy for inflammatory bowel diseases treatment. Here, oral hybrid lipid‐polymer nanocomposite made of bioadhesive peptide‐based hydrogel mixed with tofacitinib‐loaded nanoemulsions for local intestinal immunomodulation is designed. The feasibility of the nanocomposite platform and the efficacy upon oral administration in a mouse model of intestinal inflammation are demonstrated.</abstract><cop>Germany</cop><pub>Wiley Subscription Services, Inc</pub><pmid>38445812</pmid><doi>10.1002/adhm.202303280</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0001-7030-3056</orcidid><orcidid>https://orcid.org/0000-0003-2088-1442</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 2192-2640
ispartof Advanced healthcare materials, 2024-06, Vol.13 (16), p.e2303280-n/a
issn 2192-2640
2192-2659
2192-2659
language eng
recordid cdi_hal_primary_oai_HAL_hal_04526888v1
source Wiley Online Library - AutoHoldings Journals
subjects Bioaccumulation
Circular dichroism
Dichroism
Galenic pharmacology
hybrid systems
Hydrogels
Inflammatory bowel diseases
inflammatory bowel diseases (IBDs)
Intestine
Life Sciences
Lipids
Nanocomposites
Nanoemulsions
Nanoparticles
Oral administration
oral delivery
Peptides
Pharmaceutical sciences
Pharmacology
Physical properties
Rheological properties
Self-assembly
Side effects
Toxicity
title Peptide‐Based Hydrogel for Nanosystems Encapsulation: the Next Generation of Localized Delivery Systems for the Treatment of Intestinal Inflammations
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T15%3A08%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Peptide%E2%80%90Based%20Hydrogel%20for%20Nanosystems%20Encapsulation:%20the%20Next%20Generation%20of%20Localized%20Delivery%20Systems%20for%20the%20Treatment%20of%20Intestinal%20Inflammations&rft.jtitle=Advanced%20healthcare%20materials&rft.au=Andretto,%20Valentina&rft.date=2024-06-01&rft.volume=13&rft.issue=16&rft.spage=e2303280&rft.epage=n/a&rft.pages=e2303280-n/a&rft.issn=2192-2640&rft.eissn=2192-2659&rft_id=info:doi/10.1002/adhm.202303280&rft_dat=%3Cproquest_hal_p%3E3071691073%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3071691073&rft_id=info:pmid/38445812&rfr_iscdi=true